Cost of illness associated with Niemann-Pick disease type C in the UK

References

• Imrie J, Dasgupta S, Besley GT, et al. The natural history of Niemann-Pick disease type C in the UK. J Inherit Metab Dis 2007;30:51–59.
   PubMed Web of Science ®Google Scholar
• Garver WS, Francis GA, Jelinek D, et al. The National Niemann-Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A 2007;143:1204–1211.
   Google Scholar
• Vanier MT, Millat G. Niemann-Pick disease type C. Clin Genet 2003;64:269–281.
   PubMed Web of Science ®Google Scholar
• Patterson MC, Vanier MT, Suzuki K, et al. Niemann-Pick disease type C: a lipid trafficking disorder. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001;3611–3633.
   Google Scholar
• Wraith JE, Imrie J. Understanding Niemann-Pick Disease type C and its Potential Treatment. Oxford: Blackwell Publishing, 2007;1–36.
   Google Scholar
• Carstea ED, Morris JA, Coleman KG, et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 1997;277:228–231.
   PubMed Web of Science ®Google Scholar
• Naureckiene S, Sleat DE, Lackland H, et al. Identification of HE1 as the second gene of Niemann-Pick C disease. Science 2000;290: 2298–2301.
   PubMed Web of Science ®Google Scholar
• Pentchev PG, Comly ME, Kruth HS, et al. Group C Niemann-Pick disease: faulty regulation of low-density lipoprotein uptake and cholesterol storage in cultured fibroblasts. FASEB J 1987;1:40–45.
   PubMedGoogle Scholar
• Vanier MT, Rodriguez-Lafrasse C, Rousson R, et al. Type C Niemann-Pick disease: biochemical aspects and phenotypic heterogeneity. Dev Neurosci 1991;13:307–314.
   PubMedGoogle Scholar
• Vanier MT, Wenger DA, Comly ME, et al. Niemann-Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. A collaborative study on 70 patients. Clin Genet 1988;33:331–348.
   PubMed Web of Science ®Google Scholar
• Sevin M, Lesca G, Baumann N, et al. The adult form of Niemann-Pick disease type C. Brain 2007;130:120–133.
   PubMed Web of Science ®Google Scholar
• Imrie J, Vijayaraghaven S, Whitehouse C, et al. Niemann-Pick disease type C in adults. J Inherit Metab Dis 2002;25:491–500.
   PubMed Web of Science ®Google Scholar
• Pineda M, Wraith JE, Mengel E, et al. Miglustat in patients with Niemann-Pick Type C disease (NP-C): a multicentre observational retrospective cohort study. Mol Genet Metab. Early online publication. Doi: 10.1016/j.ymgme.2009.07.003.
   Google Scholar
• Pinto R, Caseiro C, Lemos M, et al. Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet 2004;12:87–92.
   PubMed Web of Science ®Google Scholar
• Poorthuis BJ, Wevers RA, Kleijer WJ, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999;105:151–156.
   PubMed Web of Science ®Google Scholar
• Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999;281:249–254.
   PubMed Web of Science ®Google Scholar
• Imrie J, Knight S, Heptinstall L, et al. Presentation and natural history of Niemann-Pick Disease Type C. Presented at Shire-sponsored Conference, Paris, 2008.
   Google Scholar
• Pentchev PG, Comly ME, Kruth HS, et al. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci USA 1985;82:8247–8251.
   PubMedGoogle Scholar
• Health UDO. NHS Reference Costs 2006–07. Available at: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_082571 [Last accessed 19 February 2009].
   Google Scholar
• Curtis L. Unit costs of health and social care 2007, Personal Social Services Research Unit, Canterbury. Available at: http://www.pssru.ac.uk/pdf/uc/uc2007/uc2007.pdf [Last accessed 19 February 2009].
   Google Scholar
• Curtis L, Netten A. Unit costs of health and social care 2004, Personal Social Services Research Unit, Canterbury. Available at: http://www.pssru.ac.uk/pdf/uc2004/uc2004.pdf [Last accessed 19 February 2009].
   Google Scholar
• London Medical Association and Royal Pharmaceutical Society of Great Britain, British National Formulary (BNF 56), 2008.
   Google Scholar
• Office of National Statistics (ONS), UK Statistics Authority. Available at: http://www.statistics.gov.uk/ [Last accessed 19 February 2009].
   Google Scholar
• Treiber A, Morand O, Clozel M. The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor miglustat in the rat. Xenobiotica 2007;37:298–314.
   PubMed Web of Science ®Google Scholar
• Zervas M, Dobrenis K, Walkley SU. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol 2001;60:49–64.
   PubMed Web of Science ®Google Scholar
• Patterson MC, Vecchio D, Prady H, et al. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol 2007;6:765–772.
   PubMed Web of Science ®Google Scholar
• Patterson MC, Vecchio D, Prady H, et al. Miglustat in Niemann-Pick type C disease (NPC): results of 24 months' treatment. Poster presented at the 57th Annual Meeting of the American Society of Human Genetics. San Diego, USA, 2007.
   Google Scholar
• Patterson MC, Vecchio D, Jacklin E, Wraith JE. Miglustat in Niemann-Pick disease Type C (NPC): long-term data from a clinical trial. Poster presented at the 58th Annual Meeting of the American Society of Human Genetics. Philadelphia, USA, 2008.
   Google Scholar
• Patterson MC, Vecchio D, Jacklin E, et al. Long-term miglustat therapy in children with Niemann-Pick disease type C. J Child Neurol, [in press].
   Google Scholar
• Robson M, Abbott J, Webb K, et al. A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients. Thorax 1992;47:684–689.
   PubMed Web of Science ®Google Scholar
• Lieu TA, Ray GT, Farmer G, et al. The cost of medical care for patients with cystic fibrosis in a health maintenance organization. Pediatrics 1999;103:e72.
   PubMed Web of Science ®Google Scholar
• Krauth C, Jalilvand N, Weite T, Busse R. Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies. Pharmacoeconomics 2003;21:1001–1024.
   PubMed Web of Science ®Google Scholar
• Wilson L. Cost-of-Illness of scleroderma: the case for rare diseases. Semin Arthritis Rheum 1997;27:73–84.
   PubMedGoogle Scholar
• Patterson MC, Platt F. Therapy of Niemann-Pick disease, type C. Biochim Biophys Acta 2004;1685:77–82.
   PubMed Web of Science ®Google Scholar
• Wraith JE, Pineda M, Sedel F, et al. Miglustat in patients with Niemann-Pick Type C disease (NP-C): a multicentre retrospective survey. Poster presented at the 58th Annual Meeting of the American Society of Human Genetics. Philadelphia, USA, 2008
   Google Scholar